Eric B Haura Selected Research

PD 180970

7/2003

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric B Haura Research Topics

Disease

88	Neoplasms (Cancer) 04/2022 - 11/2002
76	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2003
38	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2002
16	Adenocarcinoma of Lung 10/2020 - 11/2006
7	Carcinogenesis 03/2015 - 06/2005
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 02/2016
5	Neoplasm Metastasis (Metastasis) 06/2021 - 06/2005
4	Fatigue 01/2022 - 12/2018
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 05/2012
3	Adenocarcinoma 01/2015 - 09/2009
2	Nausea 01/2022 - 11/2019
2	Pneumonia (Pneumonitis) 01/2022 - 12/2011
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2012
2	Thrombocytopenia (Thrombopenia) 01/2021 - 08/2012
2	Disease Progression 01/2017 - 05/2008
2	Small Cell Carcinoma 01/2017 - 07/2003
2	Inflammation (Inflammations) 01/2015 - 12/2011
2	Rhabdomyosarcoma 05/2012 - 09/2009
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Fibrosarcoma 01/2020

Drug/Important Bio-Agent (IBA)

33	Phosphotransferases (Kinase)IBA 01/2021 - 07/2003
32	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2003
19	ErbB Receptors (EGF Receptor)IBA 10/2021 - 07/2003
16	Pharmaceutical PreparationsIBA 01/2022 - 09/2010
15	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 07/2003
12	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2006
11	Dasatinib (BMS 354825)FDA Link 01/2019 - 06/2006
9	Tyrosine Kinase InhibitorsIBA 10/2021 - 11/2006
6	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2005
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019 - 04/2010
5	Biological ProductsIBA 01/2022 - 10/2003
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2020 - 03/2005
5	CytokinesIBA 11/2019 - 07/2003
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2011 - 09/2007
4	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2021 - 01/2014
4	Anaplastic Lymphoma KinaseIBA 01/2020 - 02/2015
4	VaccinesIBA 03/2019 - 06/2013
4	ProteomeIBA 01/2019 - 10/2008
4	LigandsIBA 01/2018 - 01/2006
4	Interleukin-6 (Interleukin 6)IBA 07/2014 - 07/2003
4	Transcription Factors (Transcription Factor)IBA 12/2011 - 03/2005
4	Gefitinib (Iressa)FDA Link 11/2010 - 03/2005
4	src-Family KinasesIBA 07/2010 - 07/2003
4	Epidermal Growth Factor (EGF)IBA 01/2006 - 11/2002
3	PlatinumIBA 10/2021 - 09/2010
3	PhosphotyrosineIBA 01/2021 - 10/2010
3	Formaldehyde (Formol)FDA Link 10/2020 - 01/2019
3	Histone Deacetylase InhibitorsIBA 11/2019 - 09/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2003
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 02/2016
3	Messenger RNA (mRNA)IBA 12/2017 - 11/2012
3	Doxycycline (Periostat)FDA LinkGeneric 10/2016 - 05/2012
3	AZD 6244IBA 10/2016 - 01/2016
3	Docetaxel (Taxotere)FDA Link 01/2014 - 06/2004
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 12/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020 - 02/2014
2	ParaffinIBA 10/2020 - 01/2019
2	AfatinibIBA 01/2019 - 08/2014
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 09/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2016 - 09/2010
2	ChemokinesIBA 08/2016 - 06/2013
2	desthiobiotin (dethiobiotin)IBA 06/2016 - 02/2016
2	EnzymesIBA 06/2016 - 07/2013
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016 - 09/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 01/2015
2	tyrosine receptor (receptor, tyrosine)IBA 10/2015 - 07/2003
2	Neutralizing AntibodiesIBA 07/2014 - 03/2011
2	siltuximabIBA 07/2014 - 03/2011
2	obatoclaxIBA 01/2014 - 03/2008
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2012 - 08/2009
2	Peptides (Polypeptides)IBA 05/2012 - 04/2010
2	Cisplatin (Platino)FDA LinkGeneric 09/2009 - 03/2008
2	alvocidib (flavopiridol)IBA 06/2004 - 01/2003
1	Alanine (L-Alanine)FDA Link 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	SteroidsIBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	spartalizumabIBA 01/2022
1	amivantamab-vmjwIBA 10/2021
1	NivolumabIBA 01/2021
1	navitoclaxIBA 01/2021
1	osimertinibIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Interferon Type IIBA 01/2020
1	Glycerol KinaseIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020

Therapy/Procedure

34	Therapeutics 01/2022 - 06/2004
11	Drug Therapy (Chemotherapy) 10/2021 - 07/2002
6	Immunotherapy 01/2020 - 10/2003
3	Secondary Prevention 12/2020 - 01/2016
3	Chemoprevention 09/2014 - 06/2010
2	Adjuvant Chemotherapy 12/2016 - 11/2002
2	Precision Medicine 10/2015 - 08/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021